$NKTR has been mentioned 14 times over the past 12 months by 3 distinct FinTwit voices, with the first mention occurring on September 18, 2025. @adamfeuerstein dominates discussion of the biotech company with 12 mentions, while @kawzinvests and @stocksavvyshay each contributed 1 mention. The most recent mention came on June 15, 2026.

The most substantive discussion centered on $NKTR's rezpeg program in alopecia areata, with @adamfeuerstein reporting on 52-week results showing 27% of participants treated with low or high dose achieved clinically meaningful hair-growth outcomes defined as SALT Score 20 (80% or more scalp coverage). @adamfeuerstein noted this performance met or bettered comparator $LLY Olumiant in his coverage dated April 20, 2026.